Endogenous analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: indoleamine derived tetrahydro-beta-carbolines as potential causative factors in Parkinson's disease.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D001029:Aotus trivirgatus; D001921:Brain / Q000187:drug effects; D002243:Carbolines / Q000633:toxicity*; D004298:Dopamine / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D011725:Pyridines / Q000633:toxicity*; D013329:Structure-Activity Relationship
D002243:Carbolines; D011725:Pyridines; D015102:3,4-Dihydroxyphenylacetic Acid; C009777:2-methyltryptoline; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine; D006719:Homovanillic Acid